[lang_en] Shimla: Ratan Tata, chairman of the multibillion-dollar global Tata conglomerate, has joined NanobiosymÂ® Global Advisory Board, a NanobiosymÂ® spokesperson Jennifer Wilson disclosed to My Himachal News today.
NanobiosymÂ® has drawn up plans to invest about Rs 2000 crore for setting up an Nano-Biosym Park in Nalagarh sub-division of Himachal Pradesh for which a 500 acre patch of land has already been marked out.
Welcoming Ratan Tata on board Dr Anita Goel, chairman and CEO NanobiosymÂ® said, â€œhis example provides us with a practical roadmap for bringing cutting edge technologies into emerging global economies and extending our reach to broad markets at the â€˜bottom of the pyramidâ€™.â€
Goel, a Harvard and MIT-trained physicist and physician, has developed Gene-RADARÂ®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism.
This innovative technology could give patients worldwide real-time access to their own diagnostic information through low-cost handheld devices that could detect disease from a single drop of blood or saliva.
On joining the board Tata said â€œNanotechnology has the potential to revolutionize the way we tackle key issues facing the world today, and NanobiosymÂ® is working at the forefront of this revolution.â€
â€œDr. Goel has forged a bold model for driving technological innovation and commercialization, while maximizing global humanitarian impact. I am delighted to join the NanobiosymÂ® Global Advisory Board, and I look forward to working closely with Dr. Goel and her team.â€
Dr. Goel has been named as one of MIT Technology Reviewâ€™s top 35 science and technology innovators in the world and Time Magazine has marks Tata as one the 100 most influential persons in the world.[/lang_en][lang_en]Other members on the advisory board include Alfred Ford, director of the Ford Motor Company Fund and former US ambassador John Palmer, Vinay Singhal former CED of Fortis Healthcare, Dr. William A. Haseltine, President Haseltine Foundation for Medical Sciences and the Arts, Dr Anantha Krishnan, Director of Research & Development for Meso-, Micro- and Nano-Technology at Lawrence Livermore National Laboratory (LLNL), and Dr. Debra Peattie, a founding scientist at Vertex Pharmaceuticals.
About Nanobiosym (www.nanobiosym.com)
NanobiosymÂ® and its commercial engine NanobiosymÂ® Diagnostics create and commercialize breakthrough technologies at the nexus of physics, biomedicine, and nanotechnology. Its Gene-RADARÂ® technology platform will empower people worldwide with rapid, accurate and portable diagnostic information about their own health. Nanobiosymâ€™sÂ® Global Advisory Board comprises global thought leaders who provide guidance and strategic vision to help NanobiosymÂ® realize its mission. NanobiosymÂ® and its Board work closely with governmental, NGO, and commercial partners to bring its revolutionary technology platforms into developed and emerging world markets.
About Dr. Anita Goel
Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of NanobiosymÂ®, is an internationally recognized nanotech expert and entrepreneur. Dr. Goelâ€™s pioneering contributions to the interface of physics, medicine, and nanotechnology over the past 15 years have been recognized globally by several prestigious honors and funding awards from the United States Department of Defense agencies including Defense Advanced Research Projects Agency (DARPA), Air Force Office of Scientific Research (AFOSR), U.S. Department of Energy (DOE) and the U.S. Defense Threat Reduction Agency (DTRA). In 2005 Dr. Goel was named one of the worldâ€™s â€œTop 35 Science and Technology Innovators under the age of 35â€ by MITâ€™s Technology Review magazine and in 2006 received MITâ€™s Global Indus Technovator Award, an honor that recognizes the contributions of the top 10 leaders working globally at the forefront of science, technology, and entrepreneurship. Dr. Goel holds both a Ph.D. in physics from Harvard University and an M.D. from the Harvard-MIT Joint Division of Health Sciences and Technology (HST).
About Mr. Ratan N. Tata
Mr. Ratan N. Tata is Chairman of Tata Sons, the holding company for the Tata Group, the multibillion dollar Indian conglomerate. He is also the Chairman of two of the largest philanthropic trusts in India. Mr. Tata is a member of the Asia-Pacific Advisory Committee to the Board of Directors of the New York Stock Exchange and the International Advisory Council of Singapore’s Economic Development Board, and of the advisory boards of the Mitsubishi Corporation, JP Morgan Chase and Rolls Royce. Mr. Tata serves as President of the Court of the Indian Institute of Science and Chairman of the Tata Institute of Fundamental Research. He is a member of the Board of Trustees of Cornell University and the University of Southern California, as well as the Global Business Council on HIV/AIDS and the Program Board of the Gates Foundation’s India AIDS Initiative. He was recently named one of Time Magazine’s ‘100 Most Influential People of 2008,'[/lang_en]